{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:54:34Z","timestamp":1791258874832,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijcard.2015.03.167","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T05:40:43Z","timestamp":1427089243000},"page":"263-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease"],"prefix":"10.1016","volume":"185","author":[{"given":"Sho-ichi","family":"Yamagishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.03.167_bb0005","doi-asserted-by":"crossref","first-page":"B105","DOI":"10.1093\/geronj\/45.4.B105","article-title":"Nonenzymatic glycosylation, the Maillard reaction and the aging process","volume":"45","author":"Monnier","year":"1990","journal-title":"J. Gerontol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0010","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/rej.2012.1335","article-title":"Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders","volume":"15","author":"Yamagishi","year":"2012","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11883-000-0082-4","article-title":"Atherosclerosis and diabetes: the RAGE connection","volume":"2","author":"Schmidt","year":"2000","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0020","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2174\/1381612054367300","article-title":"Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy","volume":"11","author":"Yamagishi","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ecl.2013.07.005","article-title":"Advanced glycation endproducts in diabetes and diabetic complications","volume":"42","author":"Vlassara","year":"2013","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.coph.2013.06.009","article-title":"Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease","volume":"13","author":"Ward","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0035","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2174\/13816128113199990475","article-title":"Role of AGEs-RAGE system in cardiovascular disease","volume":"20","author":"Fukami","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0040","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/138161208784139693","article-title":"Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease","volume":"14","author":"Takeuchi","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0045","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2174\/138945011798829456","article-title":"Role of advanced glycation end products (AGEs) in osteoporosis in diabetes","volume":"12","author":"Yamagishi","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/rej.2014.1625","article-title":"Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk","volume":"18","author":"Yamagishi","year":"2015","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/dc14-1435","article-title":"Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function","volume":"38","author":"Kajikawa","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0060","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.2337\/dc12-0087","article-title":"Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography","volume":"35","author":"Tahara","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1755-5922.2011.00264.x","article-title":"Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects","volume":"30","author":"Ueda","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-5922.2010.00177.x","article-title":"Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects","volume":"30","author":"Tahara","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0075","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/dc10-1675","article-title":"Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study","volume":"34","author":"Sun","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0080","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00125-007-0687-z","article-title":"Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18year follow-up study","volume":"50","author":"Kilhovd","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0085","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/dc10-1087","article-title":"Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study","volume":"34","author":"Nin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0090","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2337\/diabetes.48.4.870","volume":"48","author":"Monnier","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0095","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/diabetes.54.11.3103","volume":"54","author":"Genuth","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0100","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/dia.2011.0034","article-title":"Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review","volume":"13","author":"Bos","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/cclm-2012-0832","article-title":"Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review","volume":"52","author":"Arsov","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/JOE-13-0407","article-title":"Advanced glycation end products are associated with arterial stiffness in type 1 diabetes","volume":"221","author":"Llaurad\u00f3","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1464-5491.2011.03562.x","article-title":"Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction","volume":"29","author":"Januszewski","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.diabet.2012.04.004","article-title":"Relationship between tissue glycation measured by autofluorescence and pulse wave velocity in young and elderly non-diabetic populations","volume":"38","author":"Watfa","year":"2012","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0130","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.metabol.2008.05.016","article-title":"Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease","volume":"57","author":"Ueno","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11255-013-0597-6","article-title":"Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis","volume":"46","author":"Mac-Way","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exger.2012.04.011","article-title":"Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?","volume":"48","author":"Hofmann","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/eurjhf\/hfq168","article-title":"Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients","volume":"13","author":"Willemsen","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cardfail.2008.03.008","article-title":"Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients","volume":"14","author":"Hartog","year":"2008","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/eurjhf\/hfq001","article-title":"Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction","volume":"12","author":"Hartog","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0160","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2174\/13816128113199990479","article-title":"Molecular imaging of vascular inflammation","volume":"20","author":"Tahara","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0165","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2741\/e178","article-title":"Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker","volume":"2","author":"Yamagishi","year":"2010","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0170","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2337\/db09-1509","article-title":"Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study","volume":"59","author":"Nin","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2013.01.016","article-title":"Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes","volume":"227","author":"Fujisawa","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2007.03.027","article-title":"Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products","volume":"197","author":"Mulder","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1797.2010.01419.x","article-title":"Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients","volume":"16","author":"Nagano","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2011.05.011","article-title":"Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus","volume":"218","author":"Mulder","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0195","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2362.2010.02329.x","article-title":"Carotid artery intima media thickness associates with skin autofluorescence in non-diabetic subjects without clinically manifest cardiovascular disease","volume":"40","author":"Lutgers","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0200","doi-asserted-by":"crossref","first-page":"e83084","DOI":"10.1371\/journal.pone.0083084","article-title":"Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosis","volume":"8","author":"den Dekker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0205","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10554-011-9805-6","article-title":"Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease","volume":"28","author":"Noordzij","year":"2012","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jdiacomp.2014.10.011","article-title":"Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes","volume":"29","author":"Rigalleau","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0215","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/dme.12005","article-title":"Skin autofluorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus-a multi-centre study","volume":"29","author":"Noordzij","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0220","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1464-5491.2011.03448.x","article-title":"Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes","volume":"29","author":"Tanaka","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0225","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00125-009-1308-9","article-title":"Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus","volume":"52","author":"Lutgers","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0230","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1744-9987.2009.00782.x","article-title":"Relationship of skin autofluorescence to cardiovascular disease in Japanese hemodialysis patients","volume":"14","author":"Tanaka","year":"2010","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0235","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2009.02.040","article-title":"Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2","volume":"381","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0240","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.metabol.2010.04.001","article-title":"Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease","volume":"60","author":"Ueno","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/bbrc.1999.0625","article-title":"Advanced glycation endproducts accelerate calcification in microvascular pericytes","volume":"258","author":"Yamagishi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0250","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/ATVBAHA.114.303378","article-title":"Skin autofluorescence associates with vascular calcification in chronic kidney disease","volume":"34","author":"Wang","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF03086239","article-title":"Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events","volume":"17","author":"Mulder","year":"2009","journal-title":"Neth. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0260","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/TP.0b013e31819d3173","article-title":"Skin-autofluorescence is an independent predictor of graft loss in renal transplant recipients","volume":"87","author":"Hartog","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2169\/internalmedicine.48.1390","article-title":"Advanced glycation end products in patients with cerebral infarction","volume":"48","author":"Ohnuki","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0270","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00125-005-1828-x","article-title":"Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy","volume":"48","author":"Meerwaldt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0275","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/dia.2011.0043","article-title":"Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes","volume":"13","author":"Araszkiewicz","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0280","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2013.0009","article-title":"Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration","volume":"15","author":"Vouillarmet","year":"2013","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0285","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/ATVBAHA.112.300016","article-title":"Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease","volume":"33","author":"de Vos","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0290","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/aor.12205","article-title":"Skin and plasma autofluorescence during hemodialysis: a pilot study","volume":"38","author":"Graaff","year":"2014","journal-title":"Artif. Organs"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0295","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1333.037","article-title":"Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease","volume":"1043","author":"Hartog","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000355692","article-title":"Tissue advanced glycation end product deposition after kidney transplantation","volume":"124","author":"Crowley","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0305","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2215\/CJN.02420311","article-title":"Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3","volume":"6","author":"McIntyre","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0310","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ndt\/gfq369","article-title":"Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients","volume":"26","author":"Tanaka","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0315","doi-asserted-by":"crossref","first-page":"e83799","DOI":"10.1371\/journal.pone.0083799","article-title":"Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study","volume":"8","author":"Tanaka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0320","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.2174\/13816128113199990480","article-title":"Role of asymmetric dimethylarginine in cardiorenal syndrome","volume":"20","author":"Ueda","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0325","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1479164113486662","article-title":"Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction","volume":"10","author":"Ando","year":"2013","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0330","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00467-014-2997-y","article-title":"Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease","volume":"30","author":"Makulska","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00467-012-2280-z","article-title":"Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease","volume":"28","author":"Makulska","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0340","article-title":"Skin autofluorescence relates to soluble receptor for advanced glycation end-products and albuminuria in diabetes mellitus","author":"Skrha","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0345","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications","volume":"31","author":"Gerrits","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0350","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabet.2009.11.003","article-title":"Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy","volume":"36","author":"Chabroux","year":"2010","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0355","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.diabet.2013.03.003","article-title":"Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus","volume":"39","author":"Genevieve","year":"2013","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0360","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jdiacomp.2014.03.003","article-title":"Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients","volume":"28","author":"Hirano","year":"2014","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0365","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1440-1797.2012.01642.x","article-title":"Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients","volume":"17","author":"Adachi","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0370","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2012.06.022","article-title":"Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis","volume":"224","author":"Jiang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0375","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"Meerwaldt","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0380","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000339282","article-title":"Skin autofluorescence: a pronounced marker of mortality in hemodialysis patients","volume":"2","author":"Gerrits","year":"2012","journal-title":"Nephron Extra"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0385","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/1744-9987.12160","article-title":"Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis","volume":"18","author":"Kimura","year":"2014","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0390","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1111\/aor.12078","article-title":"Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients","volume":"37","author":"Arsov","year":"2013","journal-title":"Artif. Organs"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0395","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11255-014-0870-3","article-title":"Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis","volume":"47","author":"Siriopol","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0400","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/dc06-1391","article-title":"Skin autofluorescence is a strong predictor of cardiac mortality in diabetes","volume":"30","author":"Meerwaldt","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2015.03.167_bb0405","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/ATVBAHA.113.302731","article-title":"Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease","volume":"34","author":"de Vos","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0410","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2215\/CJN.09510913","article-title":"Skin autofluorescence and all-cause mortality in stage 3 CKD","volume":"9","author":"Fraser","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0415","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.exger.2008.01.012","article-title":"Glycation associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects","volume":"43","author":"Corstjens","year":"2008","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ijcard.2015.03.167_bb0420","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.2337\/dc12-1077","article-title":"Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes","volume":"36","author":"Sugisawa","year":"2013","journal-title":"Diabetes Care"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315004064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315004064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:36:20Z","timestamp":1759091780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315004064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":84,"alternative-id":["S0167527315004064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.167","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}